ID CLN6_HUMAN Reviewed; 311 AA. AC Q9NWW5; A8K560; B4DDH6; Q6IAB1; Q96SR0; DT 16-JUN-2003, integrated into UniProtKB/Swiss-Prot. DT 01-OCT-2000, sequence version 1. DT 04-NOV-2026, entry version 197. DE RecName: Full=Ceroid-lipofuscinosis neuronal protein 6; DE Short=Protein CLN6; GN Name=CLN6; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Adrenal gland; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT CLN6 RP LEU-234. RA Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16572171; DOI=10.1038/nature04601; RA Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K., RA Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K., RA FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N., RA Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S., RA Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K., RA DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J., RA Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E., RA Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B., RA Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R., RA O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B., RA Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S., RA Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.; RT "Analysis of the DNA sequence and duplication history of human chromosome RT 15."; RL Nature 440:671-675(2006). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Lung, and Urinary bladder; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP SUBCELLULAR LOCATION. RX PubMed=15265688; DOI=10.1016/j.yexcr.2004.04.042; RA Mole S.E., Michaux G., Codlin S., Wheeler R.B., Sharp J.D., Cutler D.F.; RT "CLN6, which is associated with a lysosomal storage disease, is an RT endoplasmic reticulum protein."; RL Exp. Cell Res. 298:399-406(2004). RN [7] RP INTERACTION WITH CLN3. RX PubMed=17237713; DOI=10.1203/pdr.0b013e31802d8a4a; RA Persaud-Sawin D.A., Mousallem T., Wang C., Zucker A., Kominami E., RA Boustany R.M.; RT "Neuronal ceroid lipofuscinosis: a common pathway?"; RL Pediatr. Res. 61:146-152(2007). RN [8] RP INTERACTION WITH CLN5, AND SUBCELLULAR LOCATION. RX PubMed=19941651; DOI=10.1186/1471-2121-10-83; RA Lyly A., von Schantz C., Heine C., Schmiedt M.L., Sipilae T., Jalanko A., RA Kyttaelae A.; RT "Novel interactions of CLN5 support molecular networking between neuronal RT ceroid lipofuscinosis proteins."; RL BMC Cell Biol. 10:83-83(2009). RN [9] RP INTERACTION WITH CRMP2. RX PubMed=19235893; DOI=10.1002/jnr.22032; RA Benedict J.W., Getty A.L., Wishart T.M., Gillingwater T.H., Pearce D.A.; RT "Protein product of CLN6 gene responsible for variant late-onset infantile RT neuronal ceroid lipofuscinosis interacts with CRMP-2."; RL J. Neurosci. Res. 87:2157-2166(2009). RN [10] RP CHARACTERIZATION OF VARIANT CLN6 THR-241. RX PubMed=20430023; DOI=10.1016/j.yexcr.2010.04.010; RA Ng C.L., Oresic K., Tortorella D.; RT "TRAM1 is involved in disposal of ER membrane degradation substrates."; RL Exp. Cell Res. 316:2113-2122(2010). RN [11] RP VARIANT CLN6 TYR-171 DEL. RX PubMed=11791207; DOI=10.1086/338190; RA Gao H., Boustany R.-M.N., Espinola J.A., Cotman S.L., Srinidhi L., RA Antonellis K.A., Gillis T., Qin X., Liu S., Donahue L.R., Bronson R.T., RA Faust J.R., Stout D., Haines J.L., Lerner T.J., MacDonald M.E.; RT "Mutations in a novel CLN6-encoded transmembrane protein cause variant RT neuronal ceroid lipofuscinosis in man and mouse."; RL Am. J. Hum. Genet. 70:324-335(2002). RN [12] RP VARIANTS CLN6 ASP-123 AND ILE-154 DEL. RX PubMed=11727201; DOI=10.1086/338708; RA Wheeler R.B., Sharp J.D., Schultz R.A., Joslin J.M., Williams R.E., RA Mole S.E.; RT "The gene mutated in variant late-infantile neuronal ceroid lipofuscinosis RT (CLN6) and in nclf mutant mice encodes a novel predicted transmembrane RT protein."; RL Am. J. Hum. Genet. 70:537-542(2002). RN [13] RP VARIANT CLN6 ARG-300. RX PubMed=12673792; DOI=10.1002/humu.10207; RA Teixeira C.A., Espinola J., Huo L., Kohlschutter J., Persaud Sawin D.A., RA Minassian B., Bessa C.J., Guimaraes A., Stephan D.A., Sa Miranda M.C., RA MacDonald M.E., Ribeiro M.G., Boustany R.-M.N.; RT "Novel mutations in the CLN6 gene causing a variant late infantile neuronal RT ceroid lipofuscinosis."; RL Hum. Mutat. 21:502-508(2003). RN [14] RP VARIANTS CLN6 HIS-62; SER-221; THR-241; SER-265 DEL AND LEU-299, AND RP VARIANT GLN-72. RX PubMed=12815591; DOI=10.1002/humu.10227; RA Sharp J.D., Wheeler R.B., Parker K.A., Gardiner R.M., Williams R.E., RA Mole S.E.; RT "Spectrum of CLN6 mutations in variant late infantile neuronal ceroid RT lipofuscinosis."; RL Hum. Mutat. 22:35-42(2003). RN [15] RP VARIANTS CLN6 LEU-159; CYS-221 AND SER-265 DEL. RX PubMed=19201763; DOI=10.1093/brain/awn366; RA Kousi M., Siintola E., Dvorakova L., Vlaskova H., Turnbull J., Topcu M., RA Yuksel D., Gokben S., Minassian B.A., Elleder M., Mole S.E., RA Lehesjoki A.-E.; RT "Mutations in CLN7/MFSD8 are a common cause of variant late-infantile RT neuronal ceroid lipofuscinosis."; RL Brain 132:810-819(2009). RN [16] RP VARIANTS CLN4A THR-6; PHE-47; PRO-67; LYS-77; GLN-103; HIS-149 AND THR-238, RP AND VARIANTS THR-34 AND THR-308. RX PubMed=21549341; DOI=10.1016/j.ajhg.2011.04.004; RA Arsov T., Smith K.R., Damiano J., Franceschetti S., Canafoglia L., RA Bromhead C.J., Andermann E., Vears D.F., Cossette P., Rajagopalan S., RA McDougall A., Sofia V., Farrell M., Aguglia U., Zini A., Meletti S., RA Morbin M., Mullen S., Andermann F., Mole S.E., Bahlo M., Berkovic S.F.; RT "Kufs disease, the major adult form of neuronal ceroid lipofuscinosis, RT caused by mutations in CLN6."; RL Am. J. Hum. Genet. 88:566-573(2011). RN [17] RP VARIANTS CLN6 SER-17; LYS-90; PHE-104; CYS-149; PRO-169; SER-186; LEU-234; RP HIS-252; SER-259 AND THR-297, AND VARIANT THR-12. RX PubMed=21990111; DOI=10.1002/humu.21624; RA Kousi M., Lehesjoki A.E., Mole S.E.; RT "Update of the mutation spectrum and clinical correlations of over 360 RT mutations in eight genes that underlie the neuronal ceroid RT lipofuscinoses."; RL Hum. Mutat. 33:42-63(2012). RN [18] RP VARIANT GLN-72. RX PubMed=27535533; DOI=10.1038/nature19057; RG Exome Aggregation Consortium; RA Lek M., Karczewski K.J., Minikel E.V., Samocha K.E., Banks E., Fennell T., RA O'Donnell-Luria A.H., Ware J.S., Hill A.J., Cummings B.B., Tukiainen T., RA Birnbaum D.P., Kosmicki J.A., Duncan L.E., Estrada K., Zhao F., Zou J., RA Pierce-Hoffman E., Berghout J., Cooper D.N., Deflaux N., DePristo M., RA Do R., Flannick J., Fromer M., Gauthier L., Goldstein J., Gupta N., RA Howrigan D., Kiezun A., Kurki M.I., Moonshine A.L., Natarajan P., RA Orozco L., Peloso G.M., Poplin R., Rivas M.A., Ruano-Rubio V., Rose S.A., RA Ruderfer D.M., Shakir K., Stenson P.D., Stevens C., Thomas B.P., Tiao G., RA Tusie-Luna M.T., Weisburd B., Won H.H., Yu D., Altshuler D.M., RA Ardissino D., Boehnke M., Danesh J., Donnelly S., Elosua R., Florez J.C., RA Gabriel S.B., Getz G., Glatt S.J., Hultman C.M., Kathiresan S., Laakso M., RA McCarroll S., McCarthy M.I., McGovern D., McPherson R., Neale B.M., RA Palotie A., Purcell S.M., Saleheen D., Scharf J.M., Sklar P., RA Sullivan P.F., Tuomilehto J., Tsuang M.T., Watkins H.C., Wilson J.G., RA Daly M.J., MacArthur D.G.; RT "Analysis of protein-coding genetic variation in 60,706 humans."; RL Nature 536:285-291(2016). CC -!- SUBUNIT: Interacts with CRMP2 (PubMed:19235893). Interacts with CLN5 CC (PubMed:19941651). Interacts with CLN3 (PubMed:17237713). CC {ECO:0000269|PubMed:17237713, ECO:0000269|PubMed:19235893, CC ECO:0000269|PubMed:19941651}. CC -!- INTERACTION: CC Q9NWW5; Q3SXY8: ARL13B; NbExp=3; IntAct=EBI-6165897, EBI-11343438; CC Q9NWW5; P11912: CD79A; NbExp=3; IntAct=EBI-6165897, EBI-7797864; CC Q9NWW5; Q8N5K1: CISD2; NbExp=3; IntAct=EBI-6165897, EBI-1045797; CC Q9NWW5; O95471: CLDN7; NbExp=3; IntAct=EBI-6165897, EBI-740744; CC Q9NWW5; Q8IUN9: CLEC10A; NbExp=3; IntAct=EBI-6165897, EBI-2873246; CC Q9NWW5; Q7Z7G2: CPLX4; NbExp=3; IntAct=EBI-6165897, EBI-18013275; CC Q9NWW5; Q96BA8: CREB3L1; NbExp=5; IntAct=EBI-6165897, EBI-6942903; CC Q9NWW5; Q9BQA9: CYBC1; NbExp=3; IntAct=EBI-6165897, EBI-2680384; CC Q9NWW5; O00559: EBAG9; NbExp=3; IntAct=EBI-6165897, EBI-8787095; CC Q9NWW5; P29323-3: EPHB2; NbExp=3; IntAct=EBI-6165897, EBI-25838727; CC Q9NWW5; P34910-2: EVI2B; NbExp=3; IntAct=EBI-6165897, EBI-17640610; CC Q9NWW5; Q5JX71: FAM209A; NbExp=3; IntAct=EBI-6165897, EBI-18304435; CC Q9NWW5; Q8TBE3: FNDC9; NbExp=3; IntAct=EBI-6165897, EBI-12142257; CC Q9NWW5; P48165: GJA8; NbExp=3; IntAct=EBI-6165897, EBI-17458373; CC Q9NWW5; Q5T7V8: GORAB; NbExp=3; IntAct=EBI-6165897, EBI-3917143; CC Q9NWW5; P43628: KIR2DL3; NbExp=3; IntAct=EBI-6165897, EBI-8632435; CC Q9NWW5; Q9H400: LIME1; NbExp=3; IntAct=EBI-6165897, EBI-2830566; CC Q9NWW5; Q8N386: LRRC25; NbExp=3; IntAct=EBI-6165897, EBI-11304917; CC Q9NWW5; Q7Z5B4-5: RIC3; NbExp=3; IntAct=EBI-6165897, EBI-12375429; CC Q9NWW5; A1A5C7-2: SLC22A23; NbExp=3; IntAct=EBI-6165897, EBI-12081840; CC Q9NWW5; O14863: SLC30A4; NbExp=3; IntAct=EBI-6165897, EBI-13918058; CC Q9NWW5; Q16623: STX1A; NbExp=3; IntAct=EBI-6165897, EBI-712466; CC Q9NWW5; Q9Y6I9: TEX264; NbExp=3; IntAct=EBI-6165897, EBI-10329860; CC Q9NWW5; Q8IV31: TMEM139; NbExp=3; IntAct=EBI-6165897, EBI-7238458; CC Q9NWW5; Q96Q45-2: TMEM237; NbExp=3; IntAct=EBI-6165897, EBI-10982110; CC Q9NWW5; O15393-2: TMPRSS2; NbExp=3; IntAct=EBI-6165897, EBI-12345267; CC Q9NWW5; O00308: WWP2; NbExp=3; IntAct=EBI-6165897, EBI-743923; CC Q9NWW5; A0A142I5B9; Xeno; NbExp=4; IntAct=EBI-6165897, EBI-20625235; CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane CC {ECO:0000269|PubMed:15265688}; Multi-pass membrane protein CC {ECO:0000269|PubMed:15265688}. Endoplasmic reticulum CC {ECO:0000269|PubMed:19941651}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9NWW5-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9NWW5-2; Sequence=VSP_056197; CC -!- DISEASE: Ceroid lipofuscinosis, neuronal, 6 (CLN6) [MIM:601780]: An CC autosomal recessive form of neuronal ceroid lipofuscinosis. Neuronal CC ceroid lipofuscinoses are progressive neurodegenerative, lysosomal CC storage diseases characterized by intracellular accumulation of CC autofluorescent liposomal material, and clinically by seizures, CC dementia, visual loss, and/or cerebral atrophy. The lipopigment CC patterns observed most often in neuronal ceroid lipofuscinosis type 6 CC comprise mixed combinations of granular, curvilinear, and fingerprint CC profiles. {ECO:0000269|PubMed:11727201, ECO:0000269|PubMed:11791207, CC ECO:0000269|PubMed:12673792, ECO:0000269|PubMed:12815591, CC ECO:0000269|PubMed:19201763, ECO:0000269|PubMed:20430023, CC ECO:0000269|PubMed:21990111, ECO:0000269|Ref.2}. Note=The disease is CC caused by variants affecting the gene represented in this entry. CC -!- DISEASE: Ceroid lipofuscinosis, neuronal, 4A (Kufs type), autosomal CC recessive (CLN4A) [MIM:204300]: An adult-onset neuronal ceroid CC lipofuscinosis. Neuronal ceroid lipofuscinoses are progressive CC neurodegenerative, lysosomal storage diseases characterized by CC intracellular accumulation of autofluorescent liposomal material, and CC clinically by seizures, dementia, visual loss, and/or cerebral atrophy. CC CLN4A has no visual involvement and is characterized by progressive CC myoclonic epilepsy. {ECO:0000269|PubMed:21549341}. Note=The disease is CC caused by variants affecting the gene represented in this entry. CC -!- WEB RESOURCE: Name=NCL CLN6; Note=Neural Ceroid Lipofuscinoses mutation CC db; CC URL="https://www.ucl.ac.uk/ncl-disease/ncl-resource-gateway-batten-disease"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AK000568; BAA91260.1; -; mRNA. DR EMBL; AK027604; BAB55226.1; -; mRNA. DR EMBL; AK291175; BAF83864.1; -; mRNA. DR EMBL; AK293197; BAG56737.1; -; mRNA. DR EMBL; CR457244; CAG33525.1; -; mRNA. DR EMBL; AC107871; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471082; EAW77811.1; -; Genomic_DNA. DR EMBL; BC010849; AAH10849.1; -; mRNA. DR EMBL; BC013130; AAH13130.1; -; mRNA. DR CCDS; CCDS10227.1; -. [Q9NWW5-1] DR CCDS; CCDS92032.1; -. [Q9NWW5-2] DR RefSeq; NP_001397997.1; NM_001411068.1. [Q9NWW5-2] DR RefSeq; NP_060352.1; NM_017882.3. [Q9NWW5-1] DR AlphaFoldDB; Q9NWW5; -. DR BioGRID; 120318; 134. DR FunCoup; Q9NWW5; 1010. DR IntAct; Q9NWW5; 97. DR NDEx; IQUERY-CP-CLN6; 1 NDEx IQuery Curated Pathway. DR STRING; 9606.ENSP00000249806; -. DR BindingDB; Q9NWW5; -. DR ChEMBL; CHEMBL6066382; -. DR TCDB; 9.B.386.1.1; the ceroid-lipofuscinosis neuronal protein-6 (cln6) family. DR iPTMnet; Q9NWW5; -. DR PhosphoSitePlus; Q9NWW5; -. DR SwissPalm; Q9NWW5; -. DR BioMuta; CLN6; -. DR DMDM; 32129457; -. DR jPOST; Q9NWW5; -. DR MassIVE; Q9NWW5; -. DR PaxDb; 9606-ENSP00000249806; -. DR PeptideAtlas; Q9NWW5; -. DR ProteomicsDB; 3862; -. DR ProteomicsDB; 82991; -. [Q9NWW5-1] DR Pumba; Q9NWW5; -. DR Antibodypedia; 26301; 204 antibodies from 33 providers. DR DNASU; 54982; -. DR Ensembl; ENST00000249806.11; ENSP00000249806.5; ENSG00000128973.14. [Q9NWW5-1] DR Ensembl; ENST00000538696.5; ENSP00000445770.1; ENSG00000128973.14. [Q9NWW5-2] DR GeneID; 54982; -. DR KEGG; hsa:54982; -. DR MANE-Select; ENST00000249806.11; ENSP00000249806.5; NM_017882.3; NP_060352.1. DR UCSC; uc002arf.3; human. [Q9NWW5-1] DR AGR; HGNC:2077; -. DR ClinPGx; PA26604; -. DR CTD; 54982; -. DR DisGeNET; 54982; -. DR GeneCards; CLN6; -. DR GeneReviews; CLN6; -. DR HGNC; HGNC:2077; CLN6. DR HPA; ENSG00000128973; Low tissue specificity. DR MalaCards; CLN6; -. DR MIM; 204300; phenotype. DR MIM; 601780; phenotype. DR MIM; 606725; gene. DR OpenTargets; ENSG00000128973; -. DR Orphanet; 700477; Adult CLN6 disease. DR Orphanet; 700472; Juvenile CLN6 disease. DR Orphanet; 700467; Late infantile CLN6 disease. DR VEuPathDB; HostDB:ENSG00000128973; -. DR eggNOG; ENOG502QSUV; Eukaryota. DR GeneTree; ENSGT00400000022240; -. DR HOGENOM; CLU_077437_0_0_1; -. DR InParanoid; Q9NWW5; -. DR OMA; ACDMKPR; -. DR OrthoDB; 9970199at2759; -. DR PAN-GO; Q9NWW5; 3 GO annotations based on evolutionary models. DR PhylomeDB; Q9NWW5; -. DR PathwayCommons; Q9NWW5; -. DR SignaLink; Q9NWW5; -. DR Agora; ENSG00000128973; -. DR BioGRID-ORCS; 54982; 11 hits in 1158 CRISPR screens. DR ChiTaRS; CLN6; human. DR GeneWiki; CLN6; -. DR GenomeRNAi; 54982; -. DR Pharos; Q9NWW5; Tbio. DR PRO; PR:Q9NWW5; -. DR Proteomes; UP000005640; Chromosome 15. DR RNAct; Q9NWW5; protein. DR Bgee; ENSG00000128973; Expressed in monocyte and 100 other cell types or tissues. DR ExpressionAtlas; Q9NWW5; baseline and differential. DR GO; GO:0005769; C:early endosome; IDA:UniProtKB. DR GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB. DR GO; GO:0005788; C:endoplasmic reticulum lumen; IDA:UniProtKB. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell. DR GO; GO:0016020; C:membrane; HDA:UniProtKB. DR GO; GO:0045121; C:membrane raft; IDA:UniProtKB. DR GO; GO:0035727; F:lysophosphatidic acid binding; IDA:UniProtKB. DR GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB. DR GO; GO:0120146; F:sulfatide binding; IDA:UniProtKB. DR GO; GO:0008203; P:cholesterol metabolic process; IMP:UniProtKB. DR GO; GO:0001573; P:ganglioside metabolic process; IMP:UniProtKB. DR GO; GO:0030203; P:glycosaminoglycan metabolic process; IMP:UniProtKB. DR GO; GO:0007042; P:lysosomal lumen acidification; IMP:UniProtKB. DR GO; GO:0045862; P:positive regulation of proteolysis; IMP:UniProtKB. DR GO; GO:0030163; P:protein catabolic process; NAS:UniProtKB. DR InterPro; IPR029255; CLN6. DR PANTHER; PTHR16244; CEROID-LIPOFUSCINOSIS NEURONAL PROTEIN 6; 1. DR PANTHER; PTHR16244:SF2; CEROID-LIPOFUSCINOSIS NEURONAL PROTEIN 6; 1. DR Pfam; PF15156; CLN6; 1. PE 1: Evidence at protein level; KW Alternative splicing; Disease variant; Endoplasmic reticulum; Membrane; KW Neurodegeneration; Neuronal ceroid lipofuscinosis; KW Proteomics identification; Reference proteome; Transmembrane; KW Transmembrane helix. FT CHAIN 1..311 FT /note="Ceroid-lipofuscinosis neuronal protein 6" FT /id="PRO_0000089862" FT TRANSMEM 56..76 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 81..101 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 111..131 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 179..199 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 204..224 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 225..245 FT /note="Helical" FT /evidence="ECO:0000255" FT TRANSMEM 260..280 FT /note="Helical" FT /evidence="ECO:0000255" FT VAR_SEQ 1..28 FT /note="MEATRRRQHLGATGGPGAQLGASFLQAR -> MAAVAGKERRARGRPRPETL FT GAIPRREGGEAGLSRAFKPLAQAPLSCETSLRKLKFKGKK (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_056197" FT VARIANT 6 FT /note="R -> T (in CLN4A; dbSNP:rs154774636)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065834" FT VARIANT 12 FT /note="A -> T (in dbSNP:rs112239768)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066904" FT VARIANT 17 FT /note="G -> S (in CLN6; uncertain significance; FT dbSNP:rs763944821)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066905" FT VARIANT 34 FT /note="A -> T (in dbSNP:rs146198681)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065835" FT VARIANT 47 FT /note="L -> F (in CLN4A; dbSNP:rs154774635)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065836" FT VARIANT 62 FT /note="R -> H (in CLN6; dbSNP:rs751486476)" FT /evidence="ECO:0000269|PubMed:12815591" FT /id="VAR_021549" FT VARIANT 67 FT /note="L -> P (in CLN4A; dbSNP:rs154774633)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065837" FT VARIANT 72 FT /note="E -> Q (in dbSNP:rs104894483)" FT /evidence="ECO:0000269|PubMed:12815591, FT ECO:0000269|PubMed:27535533" FT /id="VAR_021550" FT VARIANT 77 FT /note="N -> K (in CLN4A; dbSNP:rs154774641)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065838" FT VARIANT 90 FT /note="N -> K (in CLN6)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066906" FT VARIANT 103 FT /note="R -> Q (in CLN4A; dbSNP:rs154774634)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065839" FT VARIANT 104 FT /note="S -> F (in CLN6; dbSNP:rs777921628)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066907" FT VARIANT 123 FT /note="G -> D (in CLN6; dbSNP:rs104894484)" FT /evidence="ECO:0000269|PubMed:11727201" FT /id="VAR_015683" FT VARIANT 149 FT /note="R -> C (in CLN6; dbSNP:rs747229909)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066908" FT VARIANT 149 FT /note="R -> H (in CLN4A; dbSNP:rs154774638)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065840" FT VARIANT 154 FT /note="Missing (in CLN6)" FT /evidence="ECO:0000269|PubMed:11727201" FT /id="VAR_015684" FT VARIANT 159 FT /note="P -> L (in CLN6; dbSNP:rs919850756)" FT /evidence="ECO:0000269|PubMed:19201763" FT /id="VAR_058436" FT VARIANT 169 FT /note="L -> P (in CLN6; dbSNP:rs1344658850)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066909" FT VARIANT 171 FT /note="Missing (in CLN6; dbSNP:rs121908079)" FT /evidence="ECO:0000269|PubMed:11791207" FT /id="VAR_015685" FT VARIANT 186 FT /note="F -> S (in CLN6)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066910" FT VARIANT 221 FT /note="Y -> C (in CLN6; dbSNP:rs764571295)" FT /evidence="ECO:0000269|PubMed:19201763" FT /id="VAR_058437" FT VARIANT 221 FT /note="Y -> S (in CLN6; dbSNP:rs764571295)" FT /evidence="ECO:0000269|PubMed:12815591" FT /id="VAR_021551" FT VARIANT 234 FT /note="F -> L (in CLN6; dbSNP:rs959199004)" FT /evidence="ECO:0000269|PubMed:21990111, ECO:0000269|Ref.2" FT /id="VAR_066911" FT VARIANT 238 FT /note="F -> T (in CLN4A; requires 2 nucleotide FT substitutions; dbSNP:rs2141136108)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065841" FT VARIANT 241 FT /note="M -> T (in CLN6; decreased protein level resulting FT from ER membrane-to-cytosol dislocation of the protein FT followed by proteasome degradation; dbSNP:rs1555438255)" FT /evidence="ECO:0000269|PubMed:12815591, FT ECO:0000269|PubMed:20430023" FT /id="VAR_021552" FT VARIANT 252 FT /note="R -> H (in CLN6; dbSNP:rs374681194)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066912" FT VARIANT 259 FT /note="G -> S (in CLN6; dbSNP:rs150363441)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066913" FT VARIANT 265 FT /note="Missing (in CLN6)" FT /evidence="ECO:0000269|PubMed:12815591, FT ECO:0000269|PubMed:19201763" FT /id="VAR_021553" FT VARIANT 297 FT /note="P -> T (in CLN6; dbSNP:rs1194940137)" FT /evidence="ECO:0000269|PubMed:21990111" FT /id="VAR_066914" FT VARIANT 299 FT /note="P -> L (in CLN6; dbSNP:rs758921701)" FT /evidence="ECO:0000269|PubMed:12815591" FT /id="VAR_021554" FT VARIANT 300 FT /note="W -> R (in CLN6; dbSNP:rs750937323)" FT /evidence="ECO:0000269|PubMed:12673792" FT /id="VAR_015686" FT VARIANT 308 FT /note="S -> T (in dbSNP:rs143578698)" FT /evidence="ECO:0000269|PubMed:21549341" FT /id="VAR_065842" FT CONFLICT 281 FT /note="W -> R (in Ref. 1; BAB55226)" FT /evidence="ECO:0000305" SQ SEQUENCE 311 AA; 35919 MW; C718E6F2DC20CE0F CRC64; MEATRRRQHL GATGGPGAQL GASFLQARHG SVSADEAART APFHLDLWFY FTLQNWVLDF GRPIAMLVFP LEWFPLNKPS VGDYFHMAYN VITPFLLLKL IERSPRTLPR SITYVSIIIF IMGASIHLVG DSVNHRLLFS GYQHHLSVRE NPIIKNLKPE TLIDSFELLY YYDEYLGHCM WYIPFFLILF MYFSGCFTAS KAESLIPGPA LLLVAPSGLY YWYLVTEGQI FILFIFTFFA MLALVLHQKR KRLFLDSNGL FLFSSFALTL LLVALWVAWL WNDPVLRKKY PGVIYVPEPW AFYTLHVSSR H //